European Journal of Medicinal Chemistry

Article	Citations
Oxidative stress mitigation by antioxidants - An overview on their chemistry and influences on health status	332
Matrix metalloproteinase-9 (MMP-9) and its inhibitors in cancer: A minireview	276
Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review	251
β-lactam antibiotics: An overview from a medicinal chemistry perspective	239
Alzheimer’s disease and its treatment by different approaches: A review	209
An insight on medicinal attributes of 1,2,4-triazoles	166
Recent developments of gallic acid derivatives and their hybrids in medicinal chemistry: A review	163
RNA-dependent RNA polymerase (RdRp) inhibitors: The current landscape and repurposing for the COVID-19 pandemic	138
Application of sulfoximines in medicinal chemistry from 2013 to 2020	133
A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review	131
Bioactive pyrrole-based compounds with target selectivity	130
hERG toxicity assessment: Useful guidelines for drug design	126
Antibacterial activities with the structure-activity relationship of coumarin derivatives	119
The development of Coronavirus 3C-Like protease (3CLpro) inhibitors from 2010 to 2020	118
Research progress of mTOR inhibitors	117
Design and discovery of boronic acid drugs	116
Small molecule selenium-containing compounds: Recent development and therapeutic applications	114
Proteolysis targeting chimera (PROTAC) in drug discovery paradigm: Recent progress and future challenges	112
Anticancer property of ginsenoside Rh2 from ginseng	106
Chalcone hybrids as privileged scaffolds in antimalarial drug discovery: A key review	100
The importance of indole and azaindole scaffold in the development of antitumor agents	97
Indole-based derivatives as potential antibacterial activity against methicillin-resistance Staphylococcus aureus (MRSA)	96
Pyrazole-based analogs as potential antibacterial agents against methicillin-resistance staphylococcus aureus (MRSA) and its SAR elucidation	95
Synthetic and medicinal perspective of quinolines as antiviral agents	86
In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target	86

Treatment for liver cancer: From sorafenib to natural products	82
Sulfonamide derivatives as potential anti-cancer agents and their SARs elucidation	82
Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine	82
Toll-like receptor 4 (TLR4) inhibitors: Current research and prospective	82
A promising antiviral candidate drug for the COVID-19 pandemic: A mini-review of remdesivir	78
Recent advance on PTP1B inhibitors and their biomedical applications	77
Recent advances in the medicinal chemistry of carbonic anhydrase inhibitors	77
A review: Pharmacological aspects of metal based 1,2,4-triazole derived Schiff bases	77
Current development of CBP/p300 inhibitors in the last decade	76
Discovery of natural anti-inflammatory alkaloids: Potential leads for the drug discovery for the treatment of inflammation	73
1,2,3-Triazole-containing hybrids with potential antibacterial activity against methicillin-resistant Staphylococcus aureus (MRSA)	73
Recent advancements in the development of bioactive pyrazoline derivatives	73
Therapeutic strategies to overcome cisplatin resistance in ovarian cancer	72
The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules	72
Agonist and antagonist ligands of toll-like receptors 7 and 8: Ingenious tools for therapeutic purposes	72
A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery	72
PROTACs to address the challenges facing small molecule inhibitors	70
A review: Biologically active 3,4-heterocycle-fused coumarins	69
Current scenario of indole derivatives with potential anti-drug-resistant cancer activity	69
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: Synthesis and clinical application	68
Recent accomplishments on the synthetic/biological facets of pharmacologically active 1H-1,2,3-triazoles	68
Cancer multidrug-resistance reversal by ABCB1 inhibition: A recent update	67
Quercetin derivatives: Drug design, development, and biological activities, a review	67
Discovery of novel resorcinol diphenyl ether-based PROTAC-like molecules as dual inhibitors and degraders of PD-L1	66
Camptothecin's journey from discovery to WHO Essential Medicine: Fifty years of promise	66
Chemotherapy and chemo-resistance in nasopharyngeal carcinoma	66
Developments of CRBN-based PROTACs as potential therapeutic agents	66
Recent progress on HDAC inhibitors with dual targeting capabilities for cancer treatment	66
Azithromycin: The First Broad-spectrum Therapeutic	65
Novel quinazoline-based EGFR kinase inhibitors: A review focussing on SAR and molecular docking studies (2015-2019)	65
A review on the structure and pharmacological activity of phenylethanoid glycosides	65
Recent advancements in the development of heterocyclic anti-inflammatory agents	64
Antimicrobial drugs bearing guanidine moieties: A review	64
Recent advances in DNA gyrase-targeted antimicrobial agents	63
Contemporary approaches and future perspectives of antibacterial photodynamic therapy (aPDT) against methicillin-resistant Staphylococcus aureus (MRSA): A systematic review	63
Penicillin binding protein 2a: An overview and a medicinal chemistry perspective	63
Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect	62
Resveratrol – A comprehensive review of recent advances in anticancer drug design and development	62
Pt(II) and Au(III) complexes containing Schiff-base ligands: A promising source for antitumor treatment	62
Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors	61
Potentials of nanotechnology in treatment of methicillin-resistant Staphylococcus aureus	61
Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies	60
Research progress of indole compounds with potential antidiabetic activity	60
Discovery of potent small molecule PROTACs targeting mutant EGFR	60
Recent advances in the design and discovery of synthetic tyrosinase inhibitors	60
A key review on oxadiazole analogs as potential methicillin-resistant Staphylococcus aureus (MRSA) activity: Structure-activity relationship studies	60
Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats	59
Exosomes from different cells: Characteristics, modifications, and therapeutic applications	59
First orally bioavailable prodrug of proteolysis targeting chimera (PROTAC) degrades cyclin-dependent kinases 2/4/6 in vivo	59
Structural insights of oxindole based kinase inhibitors as anticancer agents: Recent advances	59

A review on ferulic acid and analogs based scaffolds for the management of Alzheimer’s disease	59
Membrane active 7-thiazoxime quinolones as novel DNA binding agents to decrease the genes expression and exert potent anti-methicillin-resistant Staphylococcus aureus activity	58
Recent research progress on natural small molecule bibenzyls and its derivatives in Dendrobium species	58
Effective degradation of EGFRL858R+T790M mutant proteins by CRBN-based PROTACs through both proteosome and autophagy/lysosome degradation systems	58
Fight against novel coronavirus: A perspective of medicinal chemists	57
Improved SARS-CoV-2 Mpro inhibitors based on feline antiviral drug GC376: Structural enhancements, increased solubility, and micellar studies	57
DYRK1A inhibitors for disease therapy: Current status and perspectives	55
Synthesis and anticancer activity of thiourea derivatives bearing a benzodioxole moiety with EGFR inhibitory activity, apoptosis assay and molecular docking study	55
Discovery of unique thiazolidinone-conjugated coumarins as novel broad spectrum antibacterial agents	55
Synthesis and biological evaluation of organoselenium (NSAIDs-SeCN and SeCF3) derivatives as potential anticancer agents	55
Therapeutic progression of quinazolines as targeted chemotherapeutic agents	55
Monocarboxylate transporter 1 and 4 inhibitors as potential therapeutics for treating solid tumours: A review with structure-activity relationship insights	55
Molecular hybrids: A five-year survey on structures of multiple targeted hybrids of protein kinase inhibitors for cancer therapy	55
β-Carbolines as potential anticancer agents	55
PROTAC: A promising technology for cancer treatment	54
Synthesis of adenine dinucleosides SAM analogs as specific inhibitors of SARS-CoV nsp14 RNA cap guanine-N7-methyltransferase	54
Pyrimidine-based EGFR TK inhibitors in targeted cancer therapy	54
The role of imidazole and benzimidazole heterocycles in Chagas disease: A review	53
Natural and synthetic coumarins as antileishmanial agents: A review	53
The nano delivery systems and applications of mRNA	52
Xanthenes in Medicinal Chemistry – Synthetic strategies and biological activities	52
Targeting estrogen receptor α for degradation with PROTACs: A promising approach to overcome endocrine resistance	52
Development of Mcl-1 inhibitors for cancer therapy	51
Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity	51
Anticancer potential of spirocompounds in medicinal chemistry: A pentennial expedition	51
Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance	51
Hydroxamate siderophores: Natural occurrence, chemical synthesis, iron binding affinity and use as Trojan horses against pathogens	51
Antimalarial application of quinones: A recent update	50
Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules	50
Synthetic α-glucosidase inhibitors as promising anti-diabetic agents: Recent developments and future challenges	50
A comprehensive review on β-lapachone: Mechanisms, structural modifications, and therapeutic potentials	50
Small molecule therapeutics for tauopathy in Alzheimer’s disease: Walking on the path of most resistance	50
Recent advances of quinones as a privileged structure in drug discovery	50
Drug repositioning: Progress and challenges in drug discovery for various diseases	49
Induced protein degradation of histone deacetylases 3 (HDAC3) by proteolysis targeting chimera (PROTAC)	49
Kojic acid–natural product conjugates as mushroom tyrosinase inhibitors	49
Recent progress in Keap1-Nrf2 protein-protein interaction inhibitors	49
Discovery of selective CDK9 degraders with enhancing antiproliferative activity through PROTAC conversion	48
New manganese(II), iron(II), cobalt(II), nickel(II) and copper(II) saccharinate complexes of 2,6-bis(2-benzimidazolyl)pyridine as potential anticancer agents	48
Current status and future prospects of p38α/MAPK14 kinase and its inhibitors	48
Indole chalcones: Design, synthesis, in vitro and in silico evaluation against Mycobacterium tuberculosis	48
Comprehensive review for anticancer hybridized multitargeting HDAC inhibitors	48
Recent advances in DDR (DNA damage response) inhibitors for cancer therapy	48
Free radical scavengers: An overview on heterocyclic advances and medicinal prospects	48
The state of the art of PROTAC technologies for drug discovery	48
Coumarin–benzimidazole hybrids: A review of developments in medicinal chemistry	48
Inhibitors of gelatinases (MMP-2 and MMP-9) for the management of hematological malignancies	48
Design, synthesis and in vivo evaluation of 3-arylcoumarin derivatives of rhenium(I) tricarbonyl complexes as potent antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA)	47
Targeting mTOR for fighting diseases: A revisited review of mTOR inhibitors	47
Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease	46
Potent inhibitors of SARS-CoV-2 3C-like protease derived from N-substituted isatin compounds	46
Indomethacin-based PROTACs as pan-coronavirus antiviral agents	46
Recent research progress of Uncaria spp. based on alkaloids: phytochemistry, pharmacology and structural chemistry	46
Alzheimer's disease: Updated multi-targets therapeutics are in clinical and in progress	45
Anticancer boron-containing prodrugs responsive to oxidative stress from the tumor microenvironment	45
Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review	45
Vitamin D and its analogs as anticancer and anti-inflammatory agents	45
Novel coumarin aminophosphonates as potential multitargeting antibacterial agents against Staphylococcus aureus	45
Synergistic effects of curcumin and its analogs with other bioactive compounds: A comprehensive review	45
An insight in anti-malarial potential of indole scaffold: A review	45
Functionalized quinoxalinones as privileged structures with broad-ranging pharmacological activities	45
Pluronic-based nanovehicles: Recent advances in anticancer therapeutic applications	45
3-Methylthiazolo[3,2-a]benzimidazole-benzenesulfonamide conjugates as novel carbonic anhydrase inhibitors endowed with anticancer activity: Design, synthesis, biological and molecular modeling studies	45
Discovery of thalidomide-based PROTAC small molecules as the highly efficient SHP2 degraders	44
Quinoline anticancer agents active on DNA and DNA-interacting proteins: From classical to emerging therapeutic targets	44
The heat shock response and small molecule regulators	44
Epoxide containing molecules: A good or a bad drug design approach	44
1,2,4-Oxadiazole topsentin analogs as staphylococcal biofilm inhibitors targeting the bacterial transpeptidase sortase A	43
Andrographolide and its derivatives: Current achievements and future perspectives	43
Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes	43
A comprehensive description of GluN2B-selective N-methyl-D-aspartate (NMDA) receptor antagonists	43
Design and characterization of cereblon-mediated androgen receptor proteolysis-targeting chimeras	43
Meroterpenoids produced by fungi: Occurrence, structural diversity, biological activities, and their molecular targets	43
Antioxidant, anti-inflammatory and immunomodulatory roles of vitamins in COVID-19 therapy	43
The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy–Current progress and future direction	43
Identification of novel potent and non-toxic anticancer, anti-angiogenic and antimetastatic rhenium complexes against colorectal carcinoma	43
Optimal linker length for small molecule PROTACs that selectively target p38α and p38β for degradation	43
Dihydrofolate reductase inhibitors for use as antimicrobial agents	43
Small-molecule inhibitors of breast cancer-related targets: Potential therapeutic agents for breast cancer	42
Efficient targeted oncogenic KRASG12C degradation via first reversible-covalent PROTAC	42

Discovery of tertiary amide derivatives incorporating benzothiazole moiety as anti-gastric cancer agents in vitro via inhibiting tubulin polymerization and activating the Hippo signaling pathway	42
Design, synthesis, and in vitro and in vivo anti-angiogenesis study of a novel vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor based on 1,2,3-triazole scaffold	42
The new opportunities in medicinal chemistry of fourth-generation EGFR inhibitors to overcome C797S mutation	41
Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery	41
Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity	41
Design, synthesis and in vitro evaluation of novel SARS-CoV-2 3CLpro covalent inhibitors	41
Bench-to-bedside: Innovation of small molecule anti-SARS-CoV-2 drugs in China	41
Discovery of novel purinylthiazolylethanone derivatives as anti-Candida albicans agents through possible multifaceted mechanisms	40
The antibacterial activity of fluoroquinolone derivatives: An update (2018–2021)	40
Design, synthesis, and biological evaluation of novel miconazole analogues containing selenium as potent antifungal agents	40
Expanding the anticancer potential of 1,2,3-triazoles via simultaneously targeting Cyclooxygenase-2, 15-lipoxygenase and tumor-associated carbonic anhydrases	40
2-Aminothiazole: A privileged scaffold for the discovery of anti-cancer agents	40
Modulators of CFTR. Updates on clinical development and future directions	40
Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines	40
Design and synthesis of 3-(4-pyridyl)-5-(4-sulfamido-phenyl)-1,2,4-oxadiazole derivatives as novel GSK-3β inhibitors and evaluation of their potential as multifunctional anti-Alzheimer agents	40
Medicinal chemistry updates of novel HDACs inhibitors (2020 to present)	40
Discovery of metal-based complexes as promising antimicrobial agents	40
Elephantopinolide A-P, germacrane-type sesquiterpene lactones from Elephantopus scaber induce apoptosis, autophagy and G2/M phase arrest in hepatocellular carcinoma cells	40
Cyclic tailor-made amino acids in the design of modern pharmaceuticals	40
Novel NHC-coordinated ruthenium(II) arene complexes achieve synergistic efficacy as safe and effective anticancer therapeutics	39
Discovery of IAP-recruiting BCL-XL PROTACs as potent degraders across multiple cancer cell lines	39
Design, preparation and evaluation of different branched biotin modified liposomes for targeting breast cancer	39
Novel 3-substituted coumarins as selective human carbonic anhydrase IX and XII inhibitors: Synthesis, biological and molecular dynamics analysis	39
Design, synthesis and biological evaluation of novel naturally-inspired multifunctional molecules for the management of Alzheimer’s disease	38
New drug approvals for 2019: Synthesis and clinical applications	38
Development of novel benzofuran-based SLC-0111 analogs as selective cancer-associated carbonic anhydrase isoform IX inhibitors	38
Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)	38
Recent applications of vinyl sulfone motif in drug design and discovery	38
Development of MDM2 degraders based on ligands derived from Ugi reactions: Lessons and discoveries	38
Natural and nature-inspired stilbenoids as antiviral agents	38
Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity	38
Emerging small-molecule inhibitors of the Bruton’s tyrosine kinase (BTK): Current development	38
Synthesis and biological activities of drugs for the treatment of osteoporosis	37
p62 as a therapeutic target for tumor	37
Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR)	37
Discovery of novel cell-penetrating and tumor-targeting peptide-drug conjugate (PDC) for programmable delivery of paclitaxel and cancer treatment	37
Novel quinazolinone inhibitors of the Pseudomonas aeruginosa quorum sensing transcriptional regulator PqsR	37
Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity	37
2-substituted benzothiazoles as antiproliferative agents: Novel insights on structure-activity relationships	37
Aldose reductase and protein tyrosine phosphatase 1B inhibitors as a promising therapeutic approach for diabetes mellitus	37
Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer’s action: Design, synthesis, crystal structure and in-vitro biolog	37
STING, a promising target for small molecular immune modulator: A review	37
Antioxidant activity of novel quinazolinones bearing sulfonamide: Potential radiomodulatory effects on liver tissues via NF-κB/ PON1 pathway	36
Synthesis, and biological evaluation of 3,6-diaryl-[1,2,4]triazolo[4,3-a]pyridine analogues as new potent tubulin polymerization inhibitors	36
Review of the development of BTK inhibitors in overcoming the clinical limitations of ibrutinib	36
Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities	36
Design, synthesis, and biological evaluation of nitroisoxazole-containing spiro[pyrrolidin-oxindole] derivatives as novel glutathione peroxidase 4/mouse double minute 2 dual inhibitors that inhibit br	36
Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: An opportunity to develop new CNS drugs	36
Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases	36
Recent advance of peptide-based molecules and nonpeptidic small-molecules modulating PD-1/PD-L1 protein-protein interaction or targeting PD-L1 protein degradation	36
Targeting EZH2 for cancer therapy: From current progress to novel strategies	36
Specific stabilization of promoter G-Quadruplex DNA by 2,6-disubstituted amidoanthracene-9,10-dione based dimeric distamycin analogues and their selective cancer cell cytotoxicity	36
Advance of structural modification of nucleosides scaffold	35
Combining histone deacetylase inhibitors (HDACis) with other therapies for cancer therapy	35
Recent advances in the design and development of formyl peptide receptor 2 (FPR2/ALX) agonists as pro-resolving agents with diverse therapeutic potential	35
An unanticipated discovery towards novel naphthalimide corbelled aminothiazoximes as potential anti-MRSA agents and allosteric modulators for PBP2a	35
Recent advance on carbamate-based cholinesterase inhibitors as potential multifunctional agents against Alzheimer's disease	35
Polypharmacological drug actions of recently FDA approved antibiotics	35
A comprehensive overview of β-carbolines and its derivatives as anticancer agents	35
Synthesis of some new benzoxazole derivatives and investigation of their anticancer activities	35
Recent research and development of NDM-1 inhibitors	35
Aurora kinase inhibitors as potential anticancer agents: Recent advances	35
Small-molecule MDM2 inhibitors in clinical trials for cancer therapy	35
New insight into 20(S)-ginsenoside Rh2 against T-cell acute lymphoblastic leukemia associated with the gut microbiota and the immune system	35
Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities	35
Poly ethylene glycol (PEG)-Related controllable and sustainable antidiabetic drug delivery systems	35
Tryptophan derived natural marine alkaloids and synthetic derivatives as promising antimicrobial agents	35
Hypoxia-activated nanomedicines for effective cancer therapy	35
Development of triazolothiadiazine derivatives as highly potent tubulin polymerization inhibitors: Structure-activity relationship, in vitro and in vivo study	34
Therapeutic potential of uracil and its derivatives in countering pathogenic and physiological disorders	34
Antitubercular properties of thiazolidin-4-ones – A review	34
New deferiprone derivatives as multi-functional cholinesterase inhibitors: design, synthesis and in vitro evaluation	34
Factor XII/XIIa inhibitors: Their discovery, development, and potential indications	34
N-alkylpiperidine carbamates as potential anti-Alzheimer’s agents	34
Hydrogen sulfide donors: Therapeutic potential in anti-atherosclerosis	34
5-Fluorouracil nano-delivery systems as a cutting-edge for cancer therapy	34
Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy	34
Structure-activity relationship studies of phenothiazine derivatives as a new class of ferroptosis inhibitors together with the therapeutic effect in an ischemic stroke model	34
Recent achievements of bioluminescence imaging based on firefly luciferin-luciferase system	34
Investigating the antibacterial activity of salen/salophene metal complexes: Induction of ferroptosis as part of the mode of action	34
Dihydropyrimidinone imidazoles as unique structural antibacterial agents for drug-resistant gram-negative pathogens	34
Medicinal chemistry strategies for the development of protein tyrosine phosphatase SHP2 inhibitors and PROTAC degraders	34
Pyrimidine: A promising scaffold for optimization to develop the inhibitors of ABC transporters	34
Design, synthesis and evaluation of novel thienopyrimidine-based agents bearing diaryl urea functionality as potential inhibitors of angiogenesis	34
Discovery of a PROTAC targeting ALK with in vivo activity	33
Adenosine receptor antagonists: Recent advances and therapeutic perspective	33
An update into the medicinal chemistry of translocator protein (TSPO) ligands	33
Annual review of lysine-specific demethylase 1 (LSD1/KDM1A) inhibitors in 2021	33
Synthesis, DNA binding, antibacterial and anticancer properties of two novel water-soluble copper(II) complexes containing gluconate	33
Novel curcumin derivatives as P-glycoprotein inhibitors: Molecular modeling, synthesis and sensitization of multidrug resistant cells to doxorubicin	33
PROTACs: New method to degrade transcription regulating proteins	33
Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety	33
Purine/purine isoster based scaffolds as new derivatives of benzamide class of HDAC inhibitors	33
Discovery of coumarin derivatives as potent and selective cyclin-dependent kinase 9 (CDK9) inhibitors with high antitumour activity	33
Recent contributions of quinolines to antimalarial and anticancer drug discovery research	33